Former IP lawyer turned reform advocate, Tahir Amin, discusses flaws in the patent system, particularly in pharmaceuticals. Proposes significant reforms for a more just approach to intellectual property, challenging corporate monopolies. Explores complexities of patents, drug pricing, public funding in research, and global patent system challenges. Advocates for transparency, 'use it or lose it' principle, and socially-conscious IP protections. Considers branding impact on consumer decisions and calls for integrity in IP systems.
